Reaction Details Report a problem with these data
Target
Cannabinoid receptor 2
Ligand
BDBM176670
Substrate
n/a
Meas. Tech.
Binding Assay
IC50
11±n/a nM
Citation
 Arnaud, J; Artiaga, M; Barth, F; Hortala, L; Martinez, S; Roux, P 1,3,5-triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof US Patent  US9115121 Publication Date 8/25/2015 
Target
Name:
Cannabinoid receptor 2
Synonyms:
CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
39690.94
Organism:
Homo sapiens (Human)
Description:
P34972
Residue:
360
Sequence:
MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC
  
Inhibitor
Name:
BDBM176670
Synonyms:
US9115121, 68
Type:
Small organic molecule
Emp. Form.:
C21H20ClF2N5O4
Mol. Mass.:
479.864
SMILES:
COc1nc(NCCc2ccc(OC(F)F)cc2)nc(n1)-c1ccc(Cl)c(OCC(N)=O)c1
Structure:
Search PDB for entries with ligand similarity: